0.1％他克莫司软膏治疗青少年寻常型银屑病临床疗效观察

目的观察应用0.1%他克莫司软膏治疗青少年寻常型银屑病的临床疗效。方法选取我中心皮肤病性病门诊部治疗的寻常型银屑病未成年患者66例,利用随机数表法分为两组,每组33例,观察组应用0.1%他克莫司软膏治疗,对照组应用卤米松乳膏治疗,选取治疗前、治疗2周、治疗4周、治疗8周为观察点,比较两组患者皮损面积及严重程度的改善情况,并评价疗效。结果治疗2周、4周、8周,与治疗前相比,观察组患者的PASI(银屑病面积与严重性指数)改善水平均显著优于对照组(P <0.05);治疗期间,观察组不良反应率为6.1%,也明显低于对照组15.2%(P <0.05)。结论 0.1%他克莫司软膏用于治疗青少年寻常型银屑病安全有效,且副作用小,值得临床应用。     

Postburn leukoderma successfully treated with topical daylight psoralen UVA therapy

Postburn leukoderma is challenging to treat with different surgical and nonsurgical treatments resulting in variable outcomes. We report a case of a 56‐year‐old female with postburn leukoderma treated successfully with topical daylight psoralen UVA therapy for 6 months. The treatment was well tolerated and showed excellent improvement. In conclusion, we report the successful use of topical daylight PUVA for postburn leukoderma with almost complete repigmentation. This is a simple, convenient, and cheap nonsurgical treatment option.     

Rehabilitation of a missing ear with an implant retained auricular prosthesis

Burns can leave a patient with a severely debilitating disability even after treatment. The objectives of burn rehabilitation are to minimize the adverse effects caused by the injury while rehabilitating the patient''s physical and psychological well-being, maximizing social integration. Long-term success of maxillofacial prostheses mainly depends on the retention. Extra oral implant retained prostheses have proved to be a predictable treatment option for maxillofacial rehabilitation. Replacement of a severely deformed external ear with burned tissues may be satisfactorily accomplished by a cosmetic prosthesis anchored by implants integrated in the skull. The use of such implants is now a well-recognized method for creating a stable result in maxillofacial rehabilitation. This case report describes a safe, simple and economical method for the rehabilitation of a patient with missing right auricle using an implant supported silicone prosthesis. The implant was placed in the mastoid region of the temporal bone. Reconstruction of the ear was done with auricular silicone prosthesis, retained using magnets incorporated in an autopolymerizing resin shim to decrease the weight of the prosthesis on a single implant. This method eliminates the need of tedious laboratory procedures and exact casting and fitting requirements of a metal substructure while minimizing the overall weight and cost of the prosthesis while maintaining adequate support, esthetics and retention of the prosthesis.     

Biosynthetic cellulose compared to porcine xenograft in the treatment of partial-thickness burns: A randomised clinical trial

AimThe aim was to compare two dressing treatments for partial-thickness burns: biosynthetic cellulose dressing (BsC) (Epiprotect® S2Medical AB, Linköping, Sweden) and porcine xenograft (EZ Derm®, Mölnlycke Health Care, Gothenburg, Sweden).MethodsTwenty-four adults with partial-thickness burns were included in this randomized clinical trial conducted at The Burn Centers in Linköping and Uppsala, Sweden between June 2016 and November 2018. Time to healing was the primary outcome. Secondary outcomes were wound infection, pain, impact on everyday life, length of hospital stay, cost, and burn scar outcome (evaluated with POSAS).ResultsWe found no significant differences between the two dressing groups regarding time to healing, wound infection, pain, impact on everyday life, duration of hospital stay, cost, or burn scar outcome at the first follow up. Burn scar outcome at the 12-month follow up showed that the porcine xenograft group patients scored their scars higher on the POSAS items thickness (p = 0.048) and relief (p = 0.050). This difference was, however, not confirmed by the observer.ConclusionsThe results showed the dressings performed similarly when used in adults with burns evaluated as partial thickness.     

Lethal triad in severe burns

IntroductionHypothermia, acidaemia and coagulopathy in trauma is associated with significant mortality. This study aimed to identify the incidence of the lethal triad in major burns, and describe demographics and outcomes.MethodsPatients admitted during a 71 month period with a total body surface area burn (TBSA) ≥ 30% were identified. A structured review of a prospective database was conducted. The lethal triad was defined as a combination of coagulopathy (International normalised ratio > 1.2), hypothermia (temperature ≤ 35.5 °C) and acidaemia (pH ≤ 7.25).ResultsFifteen of 117 patients fulfilled the criteria for the lethal triad on admission. Lethal triad patients had a higher median (IQR) abbreviated burn severity index (ABSI) (12 (9–13) vs. 8.5 (6–10), p = 0.001), mean (SD) TBSA burn (59.2% (18.7) vs. 47.9% (18.1), p = 0.027), mean (SD) age (46 (22.6) vs. 33 (28.3) years, p = 0.033), and had a higher incidence of inhalational injury (p < 0.0001) and full-thickness burns (p = 0.021). Both groups received similar volumes of fluid (p > 0.05).The lethal triad was associated with increased mortality (66.7% vs. 13.7%, p < 0.0001). With logistic regression analysis and adjustment for ABSI, the lethal triad was not shown to be a predictor of mortality (p > 0.05).ConclusionBurn patients with the lethal triad have a high mortality rate which reflects the severity of the injury sustained.     

补肾壮骨膏治疗围绝经期骨质疏松症临床观察

目的观察补肾壮骨膏治疗围绝经期骨质疏松症的临床疗效。方法选取2014年3月～2017年3月在我院就诊的围绝经期骨质疏松症患者80例,随机分为观察组与对照组。观察组40例,服用补肾壮骨膏、碳酸钙片;对照组40例,口服克龄蒙、碳酸钙片。观察组及对照组以4周为1个疗程,3个疗程结束后评估两组治疗效果,检测骨骼矿物质密度(BMD)及性激素(雌激素E2、卵泡刺激素FSH)。结果 3个月后随访,观察组总有效率90.0%高于对照组82.5%,差异有统计学意义(P0.05);两组BMD治疗前后比较,差异有统计学意义(P0.01);观察组E2水平明显高于对照组,FSH水平明显低于对照组,差异有统计学意义(P0.05)。结论补肾壮骨膏治疗围绝经期骨质疏松症临床疗效显著,值得临床推广。     

烧伤创疡再生医疗技术治疗糖尿病患者足部深Ⅱ～Ⅲ度烫伤疗效分析

目的总结分析烧伤创疡再生医疗技术治疗糖尿病患者足部深Ⅱ～Ⅲ度烫伤的临床疗效。方法对2014年1月至2018年6月丰台区南苑医院烧伤创疡科收治的52例足部深Ⅱ～Ⅲ度烫伤合并糖尿病患者在全身综合治疗的基础上局部创面采用烧伤创疡再生医疗技术治疗,观察治疗效果。结果 52例患者中除9例患者创面未愈即出院外,其余43例患者均于创面完全愈合后出院,其中14例患者创面愈合时间为14～30 d,20例患者创面愈合时间为31～90 d,9例患者创面愈合时间为91～190 d。结论烧伤创疡再生医疗技术治疗糖尿病患者足部深Ⅱ～Ⅲ度烫伤,可有效促进创面愈合,减轻瘢痕增生,疗效显著,临床应用价值较高。     

Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin

PurposeTo determine whether burn time per tumor volume (BPV) (min/mL), where burn time is the total time during which radiofrequency (RF) energy is being applied, is correlated with hepatocellular carcinoma (HCC) treatment outcomes using RF ablation and lyso-thermosensitive liposomal doxorubicin (LTLD).Materials and MethodsThe HEAT study was a double-blind, randomized controlled phase III trial of RF ablation only versus RF ablation + LTLD in patients with HCCs 3–7 cm in diameter. Effect of BPV on progression-free survival and overall survival (OS) was analyzed.ResultsBPV demonstrated statistically significant differences between study groups for OS (P = .038, hazard ratio [HR] = 0.85), but not for progression-free survival (P = .389, HR = 1.059). In a separate analysis, treatment groups were independently analyzed to determine the effect of BPV within each individual group. OS improved as BPV increased for patients receiving RF ablation + LTLD (P = .017, HR = 0.836, confidence interval [0.722, 0.968]). This same association was not observed in patients receiving RF ablation only (P = .57, HR = 0.99).ConclusionsBPV may be a useful metric for RF ablation + LTLD combination therapy for solitary HCC. The analysis suggested that the burn time for the tumor needs to be adjusted depending on the tumor volume. Because this is a post hoc study, the results are only suggestive and need to be confirmed with prospective studies.